scorecardresearch
Follow Us:
Monday, June 21, 2021

WHO approves Sinovac, second Chinese-made Covid vaccine to get listed

In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.

By: Reuters | Geneva |
Updated: June 1, 2021 8:47:18 pm
Who Director General has urged the leaders of wealthy G-7 nations to boost the U.N. backed vaccination programme. (AP)

The World Health Organization (WHO) has approved a Covid-19 vaccine made by Sinovac Biotech for emergency use listing, the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.

WHO emergency listing is a signal to national regulators on a product’s safety and efficacy. It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems due to India’s suspension of vaccine exports.

Test tubes are seen in front of a displayed Sinovac logo in this illustration taken, May 21, 2021. (Reuters)

In a statement, the independent panel of experts said it recommended Sinovac’s vaccine for adults over 18, with a second dose 2-4 weeks later. There was no upper age limit as data suggested it is likely to have a protective effect in older people.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest World News, download Indian Express App.

  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement